Freedman Financial Associates, Inc. Merck & Co., Inc. Transaction History

Freedman Financial Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $385,556 - $437,047	-4,618 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$70.31 - $77.77 $1,828 - $2,022	26 Added 0.57%	4,618 $359,000
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $3,374 - $3,974	49 Added 1.08%	4,592 $354,000
Q4 2020 Feb 17, 2021	BUY	$71.77 - $79.65 $326,051 - $361,849	4,543 New	4,543 $372,000

3,828

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $279B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Freedman Financial Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Freedman Financial Associates, Inc. with notifications on news.